Charles Kamau Wairuri’s Post

📢 Upcoming Webinar Alert: Standardizing Pharmacogenomics Laboratory Processes and Reporting🔬🖥️ Join us for a critical panel discussion on the future of precision medicine and pharmacogenomics (PGx). With precision medicine at the forefront of healthcare, the need for standardized clinical laboratory processes and reporting in PGx has never been more pressing. Presented by GenomeWeb and Agena, Panel Talk: Standardizing Pharmacogenomics Laboratory Processes and Reporting will be led by past AMP president and renowned PGx thought leader Dr. Vicky Pratt, YouScript founder Kristine Ashcraft, and Glenn Sawyer, Associate Director of Clinical Genetics for Agena Bioscience, on Tuesday, March 19th, 2024, from 1:00-2:00 PM ET. Whether you're a healthcare professional, researcher, or someone interested in the latest developments in precision medicine, this webinar will provide valuable perspectives on standardizing PGx laboratory processes and reporting. Reserve your spot now! https://lnkd.in/exqTccY2 Sign up even if you can't attend, and we'll send you the recording and key takeaways! Share this post with your colleagues and friends who may be interested in learning more about PGx testing. #PrecisionMedicine #Webinar #PGx #HealthcareInnovation #Pharmacogenetics #Panel #Pharmacogenomics #PGxExperts

There is still time to register! Join us for a groundbreaking discussion on Standardizing Pharmacogenomics Laboratory Processes and Reporting! Panel Talk: Standardizing Pharmacogenomics Laboratory Processes and Reporting Tuesday, March 19th, 2024 | 1:00 PM ET Featuring industry experts: Dr. Vicky Pratt, Kristine Ashcraft, and Glenn Sawyer. Our distinguished panelists will dive into crucial topics such as: • The terminology used to characterize metabolizer status. • Identifying clinically relevant genes and variants for testing. • Aligning supporting evidence from key PGx societies. • Structuring clinical reports to meet requirements. Don't miss this opportunity to be at the forefront of the PGx testing conversation. Register now and secure your spot! For more information visit: https://hubs.li/Q02p63Pl0 Even if you can't attend live, register to get access to the recording and all the valuable takeaways. #PrecisionMedicine #Webinar #PGx #HealthcareInnovation #Pharmacogenetics #Panel #Pharmacogenomics #PGxExperts

⚫️ Now at ASCRO, Uppsala: Martin Bergstrand explains the possibilities of Model Informed Drug Development, how it can reduce time to market, cost, size of study population and increase probability of success in dose selection, formulation and route of administration among other things, to an engaged audience from different Clinical Research Organizations, (CRO). 🟠 And a tip: There are still (very) few seats left to a workshop on the topic, “An introduction to probabilistic decision support in drug development”, in Rome during PAGE, led by Martin, our CEO Peter Milligan, Chief statistician Richard Anziano and Senior Consultant Giovanni Smania. #cro #lifesciences #biosimulation #biotech

Looking forward to the insightful talks from my colleagues of CMC statistics experts, Bruno Boulanger and Pierre Lebrun in the upcoming IFPAC 2024 conference! #pharmaindustry #manufacturing #CMC #statistics

From Penicillin to Digital Therapeutics and the Pace of Change in Life Sciences: Where are the Dollars Flowing? An upcoming webinar from SCIEX provide an overview of where the industry is going relative to life sciences investing and where the industry can anticipate significant growth in the near future. Register here: https://lnkd.in/dwAHdbjV

From Penicillin to Digital Therapeutics and the Pace of Change in Life Sciences: Where are the Dollars Flowing? An upcoming webinar from SCIEX provides an overview of where the industry is going relative to life sciences investing and where the industry can anticipate significant growth in the near future. Register here: https://ow.ly/svPq50R62tg

Here is a link to Domainex's recent med chem blog reviewing Genetech's recent paper on the discovery of GNE7599. I hope you find it useful.

Prepping your slides for the 3 minute poster pitch? Don’t miss our overview of this new presentation format!

At #Domainex we are always searching the literature to keep on top of the latest developments. In the latest edition of our "Medicinal Chemistry in Review" blog series, the focus was on a paper from Genentech which discloses the discovery of GNE7599, a VHL ligand with improved potency and cellular permeability and good oral bioavailability. https://lnkd.in/enp8JRFj We hope you enjoy reading it. #DrugDiscovery #MedChem

Check out the latest Outcome index tracker, transaction highlights, and strategic analysis from Outcome Capital's #lifesciences deal team. - Targeted protein degradation therapies, in the form of molecular glues or degrader antibody conjugates, continue to catch the eye of both investors and #biopharma partners as an alternative form of #cancertherapeutics - Ginkgo Bioworks completes #diagnostics spending spree through a flurry of #acquisitions to strengthen foothold in genetic medicine capabilities - Fractyl Health breaks #medtech public market drought with #ipo debut - #strategicinsights from Outcome Capital industry expert on Viking Therapeutics, Inc. potential to shake up the #glp1 market and dethrone #pharmaceutical giants currently dominating obesity drug race